Anri Inaki
Kashiwa, 2778577, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.
Journal: Molecular pharmaceutics
Published: March 01, 2026
Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: January 08, 2026
Feasibility Study of 18F-FDG PET Short-Duration Scan in Underweight Patients with Lung Cancer.
Journal: Journal of nuclear medicine technology
Published: September 13, 2025
High-dose ¹³¹I-metaiodobenzylguanidine therapy in relapsed high-risk neuroblastoma: a descriptive analysis of clinical outcomes and associated factors.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 27, 2025
Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan.
Journal: Annals of nuclear medicine
Published: August 11, 2025
Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: July 13, 2025
Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC.
Journal: Annals of nuclear medicine
Published: April 03, 2025
Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.
Journal: Pharmaceutics
Published: November 29, 2024
Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests.
Journal: Annals of nuclear medicine
Published: June 17, 2024
Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer.
Journal: Annals of nuclear medicine
Published: December 21, 2023
A new simpler image quality index based on body size for FDG-PET/CT.
Journal: Nuclear medicine communications
Published: October 30, 2023
Last Updated: 09/26/2026